Recent Episodes
Strategic Approaches to Pediatric and AYA Survivorship Care
Karen E. Effinger, MD, MS, Children’s Healthcare of Atlanta, Atlanta, GA
Insights and Updates on Navigating the AML Landscape
Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX
CAR T-cell Therapy in 2024
Michael Tees, MD, MPH, Colorado Blood Cancer Institute, Denver, CO
Supporting Healthcare Professionals to Reduce Burnout
Alfred Lee, MD, PhD, Yale University, New Haven, CT
Creating a Roadmap for Adult Survivorship Care
Meghna Ailawadhi, M.B.B.S., M.D., Mayo Clinic, Jacksonville, FL
Highlights from attending the 2023 ASH Annual Meeting
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Categories
- All Episodes (103)
- CAR T-cell Therapy (12)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (34)
- Genomics (3)
- Health Equity (8)
- Leukemia (24)
- Lymphoma (15)
- Minimal Residual Disease (MRD) (4)
- Myelodysplastic Syndromes (6)
- Myeloma & Amyloidosis (14)
- Myeloproliferative Neoplasms (4)
- Pediatric and AYA (13)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)
